These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10845768)

  • 1. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12(S1):S75-S80. PubMed ID: 10849569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy and safety of sildenafil citrate (Viagra) and oral phentolamine for the treatment of erectile dysfunction.
    Ugarte F; Hurtado-Coll A
    Int J Impot Res; 2002 Aug; 14 Suppl 2():S48-53. PubMed ID: 12161768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of oral phentolamine mesylate (Vasomax) in men with mild to moderate erectile dysfunction.
    Padma-Nathan H; Goldstein I; Klimberg I; Coogan C; Auerbach S; Lammers P;
    Int J Impot Res; 2002 Aug; 14(4):266-70. PubMed ID: 12152116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral phentolamine as treatment for erectile dysfunction.
    Becker AJ; Stief CG; Machtens S; Schultheiss D; Hartmann U; Truss MC; Jonas U
    J Urol; 1998 Apr; 159(4):1214-6. PubMed ID: 9507837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomax for the treatment of male erectile dysfunction.
    Goldstein I; Carson C; Rosen R; Islam A
    World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.
    Montorsi F; Nathan HP; McCullough A; Brock GB; Broderick G; Ahuja S; Whitaker S; Hoover A; Novack D; Murphy A; Varanese L
    J Urol; 2004 Sep; 172(3):1036-41. PubMed ID: 15311032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of curative effect on erectile dysfunction of two drugs].
    Yang DZ; Ma XN; Yu ZJ; Jiao Y
    Zhonghua Nan Ke Xue; 2003; 9(4):260-2. PubMed ID: 12931365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with buccal phentolamine mesylate for impotence.
    Zorgniotti AW
    Int J Impot Res; 1994 Mar; 6(1):37-41. PubMed ID: 7517275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
    Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C
    J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial.
    Carson CC; Hatzichristou DG; Carrier S; Lording D; Lyngdorf P; Aliotta P; Auerbach S; Murdock M; Wilkins HJ; McBride TA; Colopy MW;
    BJU Int; 2004 Dec; 94(9):1301-9. PubMed ID: 15610110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future directions in erectile dysfunction therapy.
    Mulhall JP
    Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms.
    Traish A; Gupta S; Gallant C; Huang YH; Goldstein I
    Int J Impot Res; 1998 Dec; 10(4):215-23. PubMed ID: 9884917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
    Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
    J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.